These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 20082302)
1. Evidence of lysosomal membrane permeabilization in mucopolysaccharidosis type I: rupture of calcium and proton homeostasis. Pereira VG; Gazarini ML; Rodrigues LC; da Silva FH; Han SW; Martins AM; Tersariol IL; D'Almeida V J Cell Physiol; 2010 May; 223(2):335-42. PubMed ID: 20082302 [TBL] [Abstract][Full Text] [Related]
2. Impaired Hematopoiesis and Disrupted Monocyte/Macrophage Homeostasis in Mucopolysaccharidosis Type I Mice. Viana GM; Buri MV; Paredes-Gamero EJ; Martins AM; D'Almeida V J Cell Physiol; 2016 Mar; 231(3):698-707. PubMed ID: 26235607 [TBL] [Abstract][Full Text] [Related]
3. Cytosolic acidification and lysosomal alkalinization during TNF-alpha induced apoptosis in U937 cells. Nilsson C; Johansson U; Johansson AC; Kågedal K; Ollinger K Apoptosis; 2006 Jul; 11(7):1149-59. PubMed ID: 16699952 [TBL] [Abstract][Full Text] [Related]
4. Long-term memory for aversive training is impaired in Idua(-/-) mice, a genetic model of mucopolysaccharidosis type I. Reolon GK; Braga LM; Camassola M; Luft T; Henriques JA; Nardi NB; Roesler R Brain Res; 2006 Mar; 1076(1):225-30. PubMed ID: 16473336 [TBL] [Abstract][Full Text] [Related]
5. Intrathecal administration of AAV vectors for the treatment of lysosomal storage in the brains of MPS I mice. Watson G; Bastacky J; Belichenko P; Buddhikot M; Jungles S; Vellard M; Mobley WC; Kakkis E Gene Ther; 2006 Jun; 13(11):917-25. PubMed ID: 16482204 [TBL] [Abstract][Full Text] [Related]
6. Neonatal gene therapy of MPS I mice by intravenous injection of a lentiviral vector. Kobayashi H; Carbonaro D; Pepper K; Petersen D; Ge S; Jackson H; Shimada H; Moats R; Kohn DB Mol Ther; 2005 May; 11(5):776-89. PubMed ID: 15851016 [TBL] [Abstract][Full Text] [Related]
7. Identification and molecular characterization of alpha-L-iduronidase mutations present in mucopolysaccharidosis type I patients undergoing enzyme replacement therapy. Yogalingam G; Guo XH; Muller VJ; Brooks DA; Clements PR; Kakkis ED; Hopwood JJ Hum Mutat; 2004 Sep; 24(3):199-207. PubMed ID: 15300847 [TBL] [Abstract][Full Text] [Related]
8. Effects of propofol on intracellular Ca2+ homeostasis in human astrocytoma cells. Barhoumi R; Burghardt RC; Qian Y; Tiffany-Castiglioni E Brain Res; 2007 May; 1145():11-8. PubMed ID: 17328872 [TBL] [Abstract][Full Text] [Related]
9. Effect of neonatal administration of a retroviral vector expressing alpha-L-iduronidase upon lysosomal storage in brain and other organs in mucopolysaccharidosis I mice. Chung S; Ma X; Liu Y; Lee D; Tittiger M; Ponder KP Mol Genet Metab; 2007 Feb; 90(2):181-92. PubMed ID: 16979922 [TBL] [Abstract][Full Text] [Related]
10. Alterations of membrane lipids and in gene expression of ganglioside metabolism in different brain structures in a mouse model of mucopolysaccharidosis type I (MPS I). Kreutz F; dos Santos Petry F; Camassola M; Schein V; Guma FC; Nardi NB; Trindade VM Gene; 2013 Sep; 527(1):109-14. PubMed ID: 23774686 [TBL] [Abstract][Full Text] [Related]
12. The ER and ageing II: calcium homeostasis. Puzianowska-Kuznicka M; Kuznicki J Ageing Res Rev; 2009 Jul; 8(3):160-72. PubMed ID: 19427411 [TBL] [Abstract][Full Text] [Related]
13. L-leucyl-L-leucine methyl ester does not release cysteine cathepsins to the cytosol but inactivates them in transiently permeabilized lysosomes. Repnik U; Borg Distefano M; Speth MT; Ng MYW; Progida C; Hoflack B; Gruenberg J; Griffiths G J Cell Sci; 2017 Sep; 130(18):3124-3140. PubMed ID: 28754686 [TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of the molecular lesion causing mucopolysaccharidosis type I in cats. He X; Li CM; Simonaro CM; Wan Q; Haskins ME; Desnick RJ; Schuchman EH Mol Genet Metab; 1999 Jun; 67(2):106-12. PubMed ID: 10356309 [TBL] [Abstract][Full Text] [Related]
15. The designer aminoglycoside NB84 significantly reduces glycosaminoglycan accumulation associated with MPS I-H in the Idua-W392X mouse. Wang D; Belakhov V; Kandasamy J; Baasov T; Li SC; Li YT; Bedwell DM; Keeling KM Mol Genet Metab; 2012 Jan; 105(1):116-25. PubMed ID: 22056610 [TBL] [Abstract][Full Text] [Related]
16. alpha-L-iduronidase premature stop codons and potential read-through in mucopolysaccharidosis type I patients. Hein LK; Bawden M; Muller VJ; Sillence D; Hopwood JJ; Brooks DA J Mol Biol; 2004 Apr; 338(3):453-62. PubMed ID: 15081804 [TBL] [Abstract][Full Text] [Related]
17. Mutational and oxidative stress analysis in patients with mucopolysaccharidosis type I undergoing enzyme replacement therapy. Pereira VG; Martins AM; Micheletti C; D'Almeida V Clin Chim Acta; 2008 Jan; 387(1-2):75-9. PubMed ID: 17920576 [TBL] [Abstract][Full Text] [Related]
18. Altered Cellular Homeostasis in Murine MPS I Fibroblasts: Evidence of Cell-Specific Physiopathology. Viana GM; do Nascimento CC; Paredes-Gamero EJ; D'Almeida V JIMD Rep; 2017; 36():109-116. PubMed ID: 28220405 [TBL] [Abstract][Full Text] [Related]
19. Evidence of a lysosomal pathway for apoptosis induced by the synthetic retinoid CD437 in human leukemia HL-60 cells. Zang Y; Beard RL; Chandraratna RA; Kang JX Cell Death Differ; 2001 May; 8(5):477-85. PubMed ID: 11423908 [TBL] [Abstract][Full Text] [Related]
20. Phosphatidic acid osmotically destabilizes lysosomes through increased permeability to K+ and H+. Yi YP; Wang X; Zhang G; Fu TS; Zhang GJ Gen Physiol Biophys; 2006 Jun; 25(2):149-60. PubMed ID: 16917129 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]